SGLT2 inhibitors reduce all-cause mortality.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 33939484.
- Also identified by DOI 10.7326/ACPJ202105180-052.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Silverii GA, Monami M, Mannucci E. <b>Sodium-glucose co-transporter-2 inhibitors and all-cause mortality: a meta-analysis of randomized controlled trials.</b> Diabetes Obes Metab. 2021;23:1052-6. 33283969.
Medical subject headings
- Diabetes Mellitus, Type 2
- Sodium-Glucose Transporter 2 Inhibitors